Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...

Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...

Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages.

(Reuters) - U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for proceeds of about $300 million. The company said that it now owns ...

Feb 5 (Reuters) - Drug distributor Cencora (COR.N), opens new tab raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines. The Conshohocken ...